Literature DB >> 27681597

Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex.

Daniel T Harris1, Ningyan Wang1, Timothy P Riley2, Scott D Anderson1, Nishant K Singh2, Erik Procko1, Brian M Baker2, David M Kranz3.   

Abstract

Proteins are often engineered to have higher affinity for their ligands to achieve therapeutic benefit. For example, many studies have used phage or yeast display libraries of mutants within complementarity-determining regions to affinity mature antibodies and T cell receptors (TCRs). However, these approaches do not allow rapid assessment or evolution across the entire interface. By combining directed evolution with deep sequencing, it is now possible to generate sequence fitness landscapes that survey the impact of every amino acid substitution across the entire protein-protein interface. Here we used the results of deep mutational scans of a TCR-peptide-MHC interaction to guide mutational strategies. The approach yielded stable TCRs with affinity increases of >200-fold. The substitutions with the greatest enrichments based on the deep sequencing were validated to have higher affinity and could be combined to yield additional improvements. We also conducted in silico binding analyses for every substitution to compare them with the fitness landscape. Computational modeling did not effectively predict the impacts of mutations distal to the interface and did not account for yeast display results that depended on combinations of affinity and protein stability. However, computation accurately predicted affinity changes for mutations within or near the interface, highlighting the complementary strengths of computational modeling and yeast surface display coupled with deep mutational scanning for engineering high affinity TCRs.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  T cell receptor (TCR); cancer targets; computational analysis; immunotherapy; major histocompatibility complex (MHC); protein engineering; protein-protein interaction

Mesh:

Substances:

Year:  2016        PMID: 27681597      PMCID: PMC5114409          DOI: 10.1074/jbc.M116.748681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Cyclic coordinate descent: A robotics algorithm for protein loop closure.

Authors:  Adrian A Canutescu; Roland L Dunbrack
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  TCRs with high affinity for foreign pMHC show self-reactivity.

Authors:  Phillip D Holler; Lukasz K Chlewicki; David M Kranz
Journal:  Nat Immunol       Date:  2002-12-09       Impact factor: 25.606

3.  Stability engineering of scFvs for the development of bispecific and multivalent antibodies.

Authors:  Brian R Miller; Stephen J Demarest; Alexey Lugovskoy; Flora Huang; Xiufeng Wu; William B Snyder; Lisa J Croner; Norman Wang; Aldo Amatucci; Jennifer S Michaelson; Scott M Glaser
Journal:  Protein Eng Des Sel       Date:  2010-05-10       Impact factor: 1.650

4.  Toward high-resolution de novo structure prediction for small proteins.

Authors:  Philip Bradley; Kira M S Misura; David Baker
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

5.  Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Authors:  Boris Rodenko; Mireille Toebes; Sine Reker Hadrup; Wim J E van Esch; Annemieke M Molenaar; Ton N M Schumacher; Huib Ovaa
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.

Authors:  K Scott Weber; David L Donermeyer; Paul M Allen; David M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

7.  PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta.

Authors:  Sidhartha Chaudhury; Sergey Lyskov; Jeffrey J Gray
Journal:  Bioinformatics       Date:  2010-01-07       Impact factor: 6.937

8.  A generalized framework for computational design and mutational scanning of T-cell receptor binding interfaces.

Authors:  Timothy P Riley; Cory M Ayres; Lance M Hellman; Nishant K Singh; Michael Cosiano; Jennifer M Cimons; Michael J Anderson; Kurt H Piepenbrink; Brian G Pierce; Zhiping Weng; Brian M Baker
Journal:  Protein Eng Des Sel       Date:  2016-09-13       Impact factor: 1.650

Review 9.  Energy functions in de novo protein design: current challenges and future prospects.

Authors:  Zhixiu Li; Yuedong Yang; Jian Zhan; Liang Dai; Yaoqi Zhou
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

10.  The spatial architecture of protein function and adaptation.

Authors:  Richard N McLaughlin; Frank J Poelwijk; Arjun Raman; Walraj S Gosal; Rama Ranganathan
Journal:  Nature       Date:  2012-10-07       Impact factor: 49.962

View more
  27 in total

1.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

2.  An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.

Authors:  Nishant K Singh; Jesus A Alonso; Daniel T Harris; Scott D Anderson; Jiaqi Ma; Lance M Hellman; Aaron M Rosenberg; Elizabeth M Kolawole; Brian D Evavold; David M Kranz; Brian M Baker
Journal:  Biochemistry       Date:  2020-10-19       Impact factor: 3.162

3.  Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.

Authors:  Preeti Sharma; David M Kranz
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

Review 4.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

Review 5.  Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.

Authors:  Nishant K Singh; Timothy P Riley; Sarah Catherine B Baker; Tyler Borrman; Zhiping Weng; Brian M Baker
Journal:  J Immunol       Date:  2017-10-01       Impact factor: 5.422

6.  Circular permutation profiling by deep sequencing libraries created using transposon mutagenesis.

Authors:  Joshua T Atkinson; Alicia M Jones; Quan Zhou; Jonathan J Silberg
Journal:  Nucleic Acids Res       Date:  2018-07-27       Impact factor: 16.971

7.  Immortalization and functional screening of natively paired human T cell receptor repertoires.

Authors:  Ahmed S Fahad; Cheng-Yu Chung; Sheila N Lopez Acevedo; Nicoleen Boyle; Bharat Madan; Matias F Gutiérrez-González; Rodrigo Matus-Nicodemos; Amy D Laflin; Rukmini R Ladi; John Zhou; Jacy Wolfe; Sian Llewellyn-Lacey; Richard A Koup; Daniel C Douek; Henry H Balfour; David A Price; Brandon J DeKosky
Journal:  Protein Eng Des Sel       Date:  2022-02-17       Impact factor: 1.650

8.  T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Authors:  Preeti Sharma; Daniel T Harris; Jennifer D Stone; David M Kranz
Journal:  Cancer Immunol Res       Date:  2019-09-23       Impact factor: 11.151

9.  Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.

Authors:  Preeti Sharma; Venkata V V R Marada; Qi Cai; Monika Kizerwetter; Yanran He; Steven P Wolf; Karin Schreiber; Henrik Clausen; Hans Schreiber; David M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-15       Impact factor: 11.205

10.  Affinity Maturation of a Cyclic Peptide Handle for Therapeutic Antibodies Using Deep Mutational Scanning.

Authors:  Martijn van Rosmalen; Brian M G Janssen; Natalie M Hendrikse; Ardjan J van der Linden; Pascal A Pieters; Dave Wanders; Tom F A de Greef; Maarten Merkx
Journal:  J Biol Chem       Date:  2016-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.